The weakness in the stock was because of inspections by the American drug regulator at its Halol plant in Gujarat which resulted in eight observations, as well as a downward revision of speciality......
The deal would create a pharmaceutical colossus with annual sales of more than $60 billion Pfizer Inc secured formal board approval on Sunday for its acquisition of Botox maker Allergan Plc......
If Ranbaxy had to survive, it would have to grow abroad, induct professionals and invest in research, notes Bhupesh Bhandari Ranbaxy tasted success for the first time in the 1960s with its......
Pfizer Inc and Ranbaxy Laboratories Ltd on Friday won dismissal of a U.S. antitrust lawsuit accusing them of conspiring to delay sales of generic versions of the best-selling cholesterol drug......
Markets ended flat amid range bound trade on Monday as gains in cyclicals helped offset losses in defensive sectors. The 30-share Sensex ended up 15 points at 21,935 and the 50-share Nifty ended up......